BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra ...

Researchers determine the differential risk of dementia among men and women based on the presence of obstructive sleep apnea.

Lecanemab is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

Chardan Capital analyst Keay Nakae reiterated a Buy rating on Coya Therapeutics, Inc. (COYA – Research Report) today and set a price ...

On Tuesday, Coya Therapeutics, Inc. (NASDAQ:COYA) released results from the placebo-controlled Phase 2 trial of LD IL-2 in ...

Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has introduced LucentAD Complete, a new multi-marker ...

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not ...

A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...

They first assessed binding of synthetic Aβ42 monomers conjugated to silica nanoparticles. Lecanemab had the highest sensitivity, detecting as little as 2 pM, while limit of detection (LoD) for ...

Clumping can occur when the ratio of one amyloid beta type, Aβ42, to another form, Aβ40, gets too low. The clumping forms what is commonly referred to as ‘brain plaque’, thought to play a central role ...